PubMed

Regression and progression of valvulopathy associated with fenfluramine and phentermine.

Dahl CF, Allen MR.

Ann Intern Med. 2002 Mar 19;136(6):489. No abstract available. PMID: 11900508 [PubMed - indexed for MEDLINE]Related articlesFree article

Silver lining to the cloud over anorexogen-related cardiac valvulopathy?

St John Sutton M.

Ann Intern Med. 2001 Feb 20;134(4):335-7. No abstract available. PMID: 11182845 [PubMed - indexed for MEDLINE]Related articlesFree article

Aortic and mitral fenfluramine-phentermine valvulopathy in 64 patients treated with anorectic agents.

Volmar KE, Hutchins GM.

Arch Pathol Lab Med. 2001 Dec;125(12):1555-61.PMID: 11735689 [PubMed - indexed for MEDLINE]Related articles

The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs.

Khan MA, Herzog CA, St Peter JV, Hartley GG, Madlon-Kay R, Dick CD, Asinger RW, Vessey JT.

N Engl J Med. 1998 Sep 10;339(11):713-8.PMID: 9731086 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease.

Lepor NE, Gross SB, Daley WL, Samuels BA, Rizzo MJ, Luko SP, Hickey A, Buchbinder NA, Naqvi TZ.

Am J Cardiol. 2000 Jul 1;86(1):107-10. No abstract available. PMID: 10867106 [PubMed - indexed for MEDLINE]Related articles

Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine.

Ryan DH, Bray GA, Helmcke F, Sander G, Volaufova J, Greenway F, Subramaniam P, Glancy DL.

Obes Res. 1999 Jul;7(4):313-22.PMID: 10440587 [PubMed - indexed for MEDLINE]Related articles

Heart valve lesions in patients treated with appetite suppressants.

Pi-Sunyer FX.

Obes Res. 1999 Jul;7(4):414-6. No abstract available. PMID: 10440599 [PubMed - indexed for MEDLINE]Related articles

A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation.

Jick H, Vasilakis C, Weinrauch LA, Meier CR, Jick SS, Derby LE.

N Engl J Med. 1998 Sep 10;339(11):719-24.PMID: 9731087 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine/fenfluramine.

Gardin JM, Weissman NJ, Leung C, Panza JA, Fernicola D, Davis KD, Constantine GD, Reid CL.

JAMA. 2001 Oct 24-31;286(16):2011-4.PMID: 11667938 [PubMed - indexed for MEDLINE]Related articlesFree article

Valvular heart disease associated with fenfluramine-phentermine.

Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV.

N Engl J Med. 1997 Aug 28;337(9):581-8. Erratum in: N Engl J Med 1997 Dec 11;337(24):1783. PMID: 9271479 [PubMed - indexed for MEDLINE]Related articlesFree article

Echocardiographic prevalence of mitral and/or aortic regurgitation in patients exposed to either fenfluramine-phentermine combination or to dexfenfluramine.

Kancherla MK, Salti HI, Mulderink TA, Parker M, Bonow RO, Mehlman DJ.

Am J Cardiol. 1999 Dec 1;84(11):1335-8.PMID: 10614800 [PubMed - indexed for MEDLINE]Related articles

Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.

Gardin JM, Schumacher D, Constantine G, Davis KD, Leung C, Reid CL.

JAMA. 2000 Apr 5;283(13):1703-9.PMID: 10755496 [PubMed - indexed for MEDLINE]Related articlesFree article

Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities.

Jollis JG, Landolfo CK, Kisslo J, Constantine GD, Davis KD, Ryan T.

Circulation. 2000 May 2;101(17):2071-7.PMID: 10790349 [PubMed - indexed for MEDLINE]Related articlesFree article

[Pulmonary hypertension and heart valve diseases induced by fenfluramine? Hypothesis or certitude? Myth or reality?]

Godeau P, Cherin P, Tellier P.

Rev Med Interne. 1998 Oct;19(10):700-3. French. No abstract available. PMID: 9827440 [PubMed - indexed for MEDLINE]Related articles

Low risk of significant echocardiographic valvulopathy in patients treated with anorectic drugs.

Burger AJ, Charlamb MJ, Singh S, Notarianni M, Blackburn GL, Sherman HB.

Int J Cardiol. 2001 Jul;79(2-3):159-65.PMID: 11461737 [PubMed - indexed for MEDLINE]Related articles

The progression of fenfluramine-associated valvular heart disease assessed by echocardiography.

Mast ST, Jollis JG, Ryan T, Anstrom KJ, Crary JL.

Ann Intern Med. 2001 Feb 20;134(4):261-6.PMID: 11182835 [PubMed - indexed for MEDLINE]Related articlesFree article

Valve replacement for appetite suppressant-induced valvular heart disease.

Biswas SS, Donovan CL, Forbess JM, Royal SH, Landolfo KP.

Ann Thorac Surg. 1999 Jun;67(6):1819-22.PMID: 10391313 [PubMed - indexed for MEDLINE]Related articles

Mitral valve disease associated with use of anorexigenic medications.

Newman R.

Ann Thorac Surg. 1997 Jul;64(1):294. No abstract available. PMID: 9236401 [PubMed - indexed for MEDLINE]Related articles

Valvular heart disease associated with fenfluramine-phentermine.

Rasmussen S, Corya BC, Glassman RD.

N Engl J Med. 1997 Dec 11;337(24):1773; author reply 1775. No abstract available. PMID: 9411248 [PubMed - indexed for MEDLINE]Related articles

Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience.

Teramae CY, Connolly HM, Grogan M, Miller FA Jr.

Mayo Clin Proc. 2000 May;75(5):456-61.PMID: 10807073 [PubMed - indexed for MEDLINE]Related articles